Voya Financial Advisors, Inc. Edwards Lifesciences Corp Transaction History

Voya Financial Advisors, Inc.

$923 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $4,130 - $4,621	49 Added 1.1%	4,502 $415,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $137,680 - $181,372	-1,898 Reduced 29.89%	4,453 $425,000
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $49,861 - $62,830	808 Added 14.58%	6,351 $484,000
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $19,259 - $25,959	-278 Reduced 4.78%	5,543 $384,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $8,873 - $10,281	-109 Reduced 1.84%	5,821 $549,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $24,431 - $27,803	-329 Reduced 5.26%	5,930 $490,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $19,602 - $25,095	-287 Reduced 4.38%	6,259 $466,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $20,345 - $26,500	247 Added 3.92%	6,546 $549,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $35,897 - $53,232	-415 Reduced 6.18%	6,299 $605,000
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $82,281 - $103,570	-807 Reduced 10.73%	6,714 $786,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $53,929 - $66,254	-507 Reduced 6.32%	7,521 $983,000
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $3,704 - $4,419	36 Added 0.45%	8,028 $911,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $2.85 Million - $3.56 Million	-33,958 Reduced 80.95%	7,992 $828,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $137,296 - $158,219	1,745 Added 4.34%	41,950 $3.48 Million
Q4 2020 Mar 05, 2021	BUY	$71.69 - $91.23 $303,965 - $386,815	4,240 Added 11.79%	40,205 $3.6 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $276,352 - $359,640	4,113 Added 12.91%	35,965 $2.82 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.26 Million - $1.68 Million	21,841 Added 218.17%	31,852 $2.16 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $60,219 - $93,069	1,149 Added 12.97%	10,011 $1.96 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $10,038 - $11,492	140 Added 1.61%	8,862 $2.06 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $20,249 - $24,816	329 Added 3.92%	8,722 $1.9 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $29,820 - $34,459	535 Added 6.81%	8,393 $1.56 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $20,401 - $27,285	426 Added 5.73%	7,858 $1.48 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $32,626 - $40,028	703 Added 10.45%	7,432 $1.12 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $34,686 - $44,044	759 Added 12.71%	6,729 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $9,593 - $11,593	226 Added 3.93%	5,970 $876,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $2,305 - $2,941	-62 Reduced 1.07%	5,744 $786,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $574 - $669	17 Added 0.29%	5,806 $665,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $210,082 - $224,786	5,789	5,789 $630,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.

Account